The arrival of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable excitement within the weight loss community. This novel dual GIP and GLP-1 receptor medication suggests to deliver significant improvements in fat loss compared to previous therapies. Initial clinical data have indica